PNC Financial Services Group
FENC icon

PNC Financial Services Group’s Fennec Pharmaceuticals FENC Stock Holding History

PNC Financial Services Group’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.7K Sell
629
-16
-2% -$176 ﹤0.01% 4373
2026
Q2 		$6.93K Buy
645
+135
+26% +$1.1K ﹤0.01% 4262
2026
Q1 		$3.14K Sell
510
-127
-20% -$981 ﹤0.01% 4445
2025
Q4 		$4.9K Sell
637
-331
-34% -$2.72K ﹤0.01% 4239
2025
Q3 		$9.06K Buy
968
+23
+2% +$199 ﹤0.01% 3978
2025
Q2 		$7.84K Hold
945
– – ﹤0.01% 3973
2025
Q1 		$5.76K Hold
945
– – ﹤0.01% 4013
2024
Q4 		$5.97K Buy
+945
New +$4.84K ﹤0.01% 3979
2024
Q3 		– Sell
-112
Closed -$684 – 4838
2024
Q2 		$684 Buy
+112
New +$930 ﹤0.01% 4484
2024
Q1 		– Sell
-87
Closed -$976 – 4729
2023
Q4 		$976 Buy
+87
New +$721 ﹤0.01% 4320

Other funds holding FENC

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Sierra Summit Advisors
Sierra Summit Advisors Incline Village, Nevada $852M AUM 73.11% 1-Year Est. Return
Legato Capital Management
Legato Capital Management San Francisco, California $1.11B AUM 60.78% 1-Year Est. Return
Thompson Siegel & Walmsley
Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

PNC Financial Services Group's FENC Position: Q3 2026 in Review

PNC Financial Services Group reduced its Fennec Pharmaceuticals (FENC) stake by 2.5% in Q3 2026, selling an estimated $176 and leaving 629 shares worth $6.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4373.

PNC Financial Services Group first reported a position in FENC in Q4 2023 and has held it in 10 quarters since. The position peaked at $9.06K in Q3 2025. 48 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

  • PNC Financial Services Group held 629 shares of Fennec Pharmaceuticals worth $6.7K as of Q3 2026.
  • PNC Financial Services Group sold 16 Fennec Pharmaceuticals shares in Q3 2026, an estimated $176.
  • Fennec Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4373 holding.
  • PNC Financial Services Group first reported a position in Fennec Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • PNC Financial Services Group's Fennec Pharmaceuticals position peaked at $9.06K in Q3 2025.
  • 48 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.